Literature DB >> 9218523

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

F Ahmad1, J L Azevedo, R Cortright, G L Dohm, B J Goldstein.   

Abstract

Obese human subjects have increased protein-tyrosine phosphatase (PTPase) activity in adipose tissue that can dephosphorylate and inactivate the insulin receptor kinase. To extend these findings to skeletal muscle, we measured PTPase activity in the skeletal muscle particulate fraction and cytosol from a series of lean controls, insulin-resistant obese (body mass index > 30) nondiabetic subjects, and obese individuals with non-insulin-dependent diabetes. PTPase activities in subcellular fractions from the nondiabetic obese subjects were increased to 140-170% of the level in lean controls (P < 0.05). In contrast, PTPase activity in both fractions from the obese subjects with non-insulin-dependent diabetes was significantly decreased to 39% of the level in controls (P < 0.05). By immunoblot analysis, leukocyte antigen related (LAR) and protein-tyrosine phosphatase 1B had the greatest increase (threefold) in the particulate fraction from obese, nondiabetic subjects, and immunodepletion of this fraction using an affinity-purified antibody directed at the cytoplasmic domain of leukocyte antigen related normalized the PTPase activity when compared to the activity from control subjects. These findings provide further support for negative regulation of insulin action by specific PTPases in the pathogenesis of insulin resistance in human obesity, while other regulatory mechanisms may be operative in the diabetic state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218523      PMCID: PMC508209          DOI: 10.1172/JCI119552

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells.

Authors:  F Ahmad; B J Goldstein
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

Review 3.  Some endocrine and metabolic aspects of obesity.

Authors:  D Rabinowitz
Journal:  Annu Rev Med       Date:  1970       Impact factor: 13.739

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.

Authors:  D Worm; J Vinten; P Staehr; J E Henriksen; A Handberg; H Beck-Nielsen
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

6.  Phosphorylation of the insulin receptor in cultured hepatoma cells and a solubilized system.

Authors:  M Kasuga; M F White; C R Kahn
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

7.  Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.

Authors:  J Meyerovitch; J M Backer; C R Kahn
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

8.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.

Authors:  G L Dohm; E B Tapscott; W J Pories; D J Dabbs; E G Flickinger; D Meelheim; T Fushiki; S M Atkinson; C W Elton; J F Caro
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

Authors:  O G Kolterman; J Insel; M Saekow; J M Olefsky
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

10.  A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen.

Authors:  M Streuli; N X Krueger; L R Hall; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  58 in total

1.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Authors:  Z Y Jiang; Y W Lin; A Clemont; E P Feener; K D Hein; M Igarashi; T Yamauchi; M F White; G L King
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Structure-based prediction of free energy changes of binding of PTP1B inhibitors.

Authors:  Jing Wang; Shek Ling Chan; Kal Ramnarayan
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

4.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.

Authors:  K Loh; T L Merry; S Galic; B J Wu; M J Watt; S Zhang; Z-Y Zhang; B G Neel; T Tiganis
Journal:  Diabetologia       Date:  2011-11-29       Impact factor: 10.122

5.  Protein tyrosine phosphatase-1B (PTP-1B) knockdown improves palmitate-induced insulin resistance in C2C12 skeletal muscle cells.

Authors:  Salar Bakhtiyari; Reza Meshkani; Mohammad Taghikhani; Bagher Larijani; Khosrow Adeli
Journal:  Lipids       Date:  2010-02-23       Impact factor: 1.880

6.  Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  J Endocrinol       Date:  2005-01       Impact factor: 4.286

Review 7.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

8.  MSI-1436 reduces acute food intake without affecting dopamine transporter activity.

Authors:  Mitchell F Roitman; Seth Wescott; Jackson J Cone; Michael P McLane; Henry R Wolfe
Journal:  Pharmacol Biochem Behav       Date:  2010-05-15       Impact factor: 3.533

9.  Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.

Authors:  A Sorokin; E Reed
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

Review 10.  Current views on type 2 diabetes.

Authors:  Yi Lin; Zhongjie Sun
Journal:  J Endocrinol       Date:  2009-09-21       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.